Research
Hormonal
Curcumin ameliorates diabetes-associated complications including neuropathy, nephropathy, and vascular dysfunction through anti-inflammatory and antioxidant mechanisms.
Curcumin shows promise in reducing the risk of diabetes complications like nerve and kidney damage in animal studies by lowering inflammation and oxidative stress. Human application requires more robust clinical trials.
ModerateSupportsMEDIUM confidence
Curcumin has been actively involved in modulating the diabetic neuropathic disorders... Curcumin may modulate antioxidant factors... and inflammatory parameters... in the retina of STZ-induced diabetic rats.
Why this rating
Based on animal models and mechanistic studies; limited human clinical trial evidence cited.
Source
Curcumin and Diabetes: A Systematic Review
Dongwei Zhang et al. · Evidence-based Complementary and Alternative Medicine · 2013
DOI 10.1155/2013/636053
systematic_reviewCited 373×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →